These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1414494)

  • 1. Chronic adaptation of dog parathyroid function to a low-calcium-high-sodium-vitamin D-deficient diet.
    Cloutier M; Gascon-Barré M; D'Amour P
    J Bone Miner Res; 1992 Sep; 7(9):1021-8. PubMed ID: 1414494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of involution of hyperplastic parathyroid glands in dogs: adaptation via a decrease in the calcium stimulation set point and a change in secretion profile.
    Cloutier M; Brossard JH; Gascon-Barré M; D'Amour P
    J Bone Miner Res; 1994 May; 9(5):621-9. PubMed ID: 8053390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin.
    Charhon SA; Chapuy MC; Delvin EE; Meunier PJ
    Miner Electrolyte Metab; 1985; 11(2):117-22. PubMed ID: 3838794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of serum parathyroid hormone and ionized calcium concentrations during reproduction in rats fed a low calcium diet.
    Garner SC; Peng TC; Toverud SU
    J Bone Miner Res; 1988 Jun; 3(3):319-23. PubMed ID: 3213625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Ca2+ concentration on the clearance and circulating levels of intact and carboxy-terminal iPTH in pentobarbital-anesthetized dogs.
    D'Amour P; Rousseau L; Rocheleau B; Pomier-Layrargues G; Huet PM
    J Bone Miner Res; 1996 Aug; 11(8):1075-85. PubMed ID: 8854243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating parathyroid hormone concentrations in normal and vitamin D-deprived rat pups determined with an N-terminal-specific radioimmunoassay.
    Toverud SU; Boass A; Garner SC; Endres DB
    Bone Miner; 1986 Apr; 1(2):145-55. PubMed ID: 3508722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute PTH response to oral calcium load and seasonal variation of vitamin D status in healthy young adult subjects.
    Guillemant J; Guillemant S
    Eur J Clin Nutr; 1996 Jul; 50(7):469-72. PubMed ID: 8862484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
    Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
    Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
    Portale AA; Booth BE; Halloran BP; Morris RC
    J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of calcitriol and parathyroid hormone on serum aluminum in vitamin D-depleted rabbits fed an aluminum-supplemented diet.
    Long JF; Nagode LA; Steinmeyer CL; Renkes G
    Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):3-14. PubMed ID: 8165367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better functional mobility in community-dwelling elderly is related to D-hormone serum levels and to daily calcium intake.
    Dukas L; Staehelin HB; Schacht E; Bischoff HA
    J Nutr Health Aging; 2005; 9(5):347-51. PubMed ID: 16222401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
    Fujimori A; Sakai M; Yoshiya K; Shin J; Kim JI; Inaba Y; Miyamoto T; Inoue S; Fukagawa M
    Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolism.
    Bell NH; Epstein S; Shary J; Greene V; Oexmann MJ; Shaw S
    J Bone Miner Res; 1988 Oct; 3(5):489-95. PubMed ID: 2848397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism.
    Insogna KL; Mitnick ME; Stewart AF; Burtis WJ; Mallette LE; Broadus AE
    N Engl J Med; 1985 Oct; 313(18):1126-30. PubMed ID: 2995810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25-dihydroxyvitamin D in primary hyperparathyroidism?
    Frølich A; Storm T; Thode J
    Miner Electrolyte Metab; 1996; 22(4):203-6. PubMed ID: 8807622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure.
    Panichi V; Andreini B; De Pietro S; Migliori M; Taccola D; Giovannini L; Ferdeghini M; Palla R
    Clin Nephrol; 1998 Apr; 49(4):245-50. PubMed ID: 9582556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.